Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of August 14, 2025 • 11:31 PM ET

Date/Time Source News Release
08/07/2025 05:30 PM EDT Business Wire Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
08/05/2025 04:01 PM EDT Business Wire Gossamer Bio Announces Second Quarter 2025 Financial Results and Provides Business Update
06/16/2025 07:31 AM EDT Business Wire Gossamer Bio Announces Completion of Enrollment in Registrational Phase 3 PROSERA Study for the Treatment of PAH
06/06/2025 05:30 PM EDT Business Wire Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05/21/2025 07:00 AM EDT GlobeNewswire Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream
05/15/2025 04:01 PM EDT Business Wire Gossamer Bio Announces First Quarter 2025 Financial Results and Provides Business Update, Including Closure of New Patient Screening in Phase 3 PROSERA Study
05/12/2025 04:01 PM EDT Business Wire Gossamer Bio to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 15, 2025
05/07/2025 05:30 PM EDT Business Wire Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05/07/2025 04:01 PM EDT Business Wire Gossamer Bio to Present Preclinical Data at the American Thoracic Society (ATS) 2025 International Conference
04/08/2025 05:30 PM EDT Business Wire Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Page

Additional News

As of August 14, 2025 • 11:31 PM ET

Date/Time Source News Release
08/07/2025 05:31 AM EDT US Earnings Reports Expected earnings - Gossamer Bio Inc.
08/05/2025 05:55 PM EDT Zacks Gossamer Bio (GOSS) Reports Q2 Loss, Beats Revenue Estimates
08/05/2025 05:10 PM EDT SeekingAlpha Gossamer Bio GAAP EPS of -$0.17 in-line, revenue of $11.49M beats by $6.08M
08/05/2025 08:40 AM EDT Zacks Harmony Biosciences Holdings, Inc. (HRMY) Misses Q2 Earnings and Revenue Estimates
07/30/2025 07:05 AM EDT Zacks GSK (GSK) Q2 Earnings and Revenues Beat Estimates
05/15/2025 09:30 PM EDT SeekingAlpha Gossamer Bio, Inc. (GOSS) Q1 2025 Earnings Conference Call Transcript
05/15/2025 05:15 PM EDT Zacks Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates
05/15/2025 04:39 PM EDT SeekingAlpha Gossamer Bio GAAP EPS of -$0.16 beats by $0.02, revenue of $9.9M beats by $5.95M
05/15/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 15th, 2025
05/15/2025 05:30 AM EDT US Earnings Reports Expected earnings - Gossamer Bio Inc.
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.